drugset / Trial / NCT03480009

Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion

NCT03480009 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates dextromethorphan as a non-opioid adjunctive medication for pain control during medication abortion. This is double-blinded, four-arm randomized controlled trial enrolling 156 women over a period of 9-12 months: Receiving narcotics+dextromethorphan, narcotics and placebo (microcrystalline cellulose), no narcotics and dextromethorphan and no narcotics and placebo (microcrystalline cellulose).

Timeline

Start
2018-07-28
Primary completion
2019-06-30
Completion
2019-06-30

Outcome

Missed primary endpoint

paper Worst pain scores for participants receiving dextromethorphan versus placebo (8.0 vs 7.0, p = 0.06) did not differ. PMID 36332661 ↗

paper Total milligram usage of ibuprofen (800 mg vs 610 mg, p =.62), acetaminophen (1000 mg vs 1300 mg, p = 0.62), and opioids (10 mg vs 15 mg, p = 0.51) did not differ between the randomization groups. PMID 36332661 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextromethorphan Unknown 30 mg —
Background Oxycodone Other / unclassified — —

Indications

No indication recorded.